Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndrome

被引:2
作者
Yu, Nannan [1 ]
Ouyang, Xiaojun [1 ]
Li, Jie [1 ]
Gao, Jie [1 ]
Zeng, Shuhan [1 ]
Zhuang, Hongjie [1 ]
Jiang, Mengjie [1 ]
Pei, Yuxin [1 ]
Jiang, Xiaoyun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat Nephrol & Rheumatol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Secondary steroid-resistant nephrotic syndrome; acute kidney injury; children; risk factors; outcome; ACUTE KIDNEY INJURY; CHILDHOOD; RECOVERY;
D O I
10.1080/0886022X.2024.2314637
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute kidney injury (AKI) is increasingly prevalent in children with nephrotic syndrome (NS). It is associated with adverse outcomes in NS, especially steroid-resistant nephrotic syndrome (SRNS). The incidence, risk factors and outcomes of AKI in secondary SRNS remain undefined. The main objectives of this study were to determine the risk factors and prognosis of AKI in hospitalized children with secondary SRNS. Material and methods: This retrospective study was conducted from January 2014 to December 2019, involving 172 hospitalizations with secondary SRNS admitted to the First Affiliated Hospital of Sun Yat-sen University. AKI was defined and classified in accordance with the 2012 Kidney Disease Improving Global Outcomes (KDIGO) guidelines. Results: AKI was found in 67 (39.0%) of 172 hospitalizations with secondary SRNS. Average age of onset in our group is 4.4 (3.1, 6.7) years with AKI and 3.7 (1.8, 5.6) years without AKI. Urea nitrogen level is 5.9 (4.1, 10.0) mmol/L with AKI and 5.1 (3.7, 7.0) mmol/L. Uric acid level is 446.0 (340.0, 567.0) umol/L with AKI and 401.0 (303.0, 496.0) umol/L. 24-h urinary protein level is 4.14 (2.9, 6.5) g with AKI and 2.5 (1.3, 5.3) without AKI. Multivariate logistic regression revealed that infection (OR = 5.287; 95% confidence interval, 2.349 to 11.899; p < 0.001), age at onset (OR = 1.180; 95% confidence interval, 1.032 to 1.349; p = 0.015) and uric acid level (OR = 1.003; 95% confidence interval, 1.000 to 1.006; p = 0.031) were significantly associated with the development of AKI in children with secondary SRNS. Among 72 children with secondary SRNS, six went to end-stage kidney disease (ESKD). Children in the AKI group were more likely to progress to ESKD compared with children in the non-AKI group (p = 0.017) with a median follow-up of 48.5months. Conclusion: AKI occurred in 39.0% of total hospitalizations associated with secondary SRNS. Risk factors including infection, age of onset, and uric acid level are associated with AKI in children with secondary SRNS. Furthermore, AKI was identified as a risk factor for the progression of secondary SRNS to ESKD.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome
    Hari, Pankaj
    Khandelwal, Priyanka
    Boyer, Olivia
    Bhimma, Rajendra
    Cano, Francesco
    Christian, Martin
    Duzova, Ali
    Iijima, Kazumoto
    Kang, Hee
    Qian, Shen
    Safouh, Hesham
    Samuels, Susan
    Smoyer, William
    Vivarelli, Marina
    Bagga, Arvind
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2025, 40 (03) : 865 - 872
  • [32] Mutational analysis of podocyte genes in children with sporadic steroid-resistant nephrotic syndrome
    Feng, D. N.
    Yang, Y. H.
    Wang, D. J.
    Meng, D. C.
    Fu, R.
    Wang, J. J.
    Yu, Z. H.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 9514 - 9522
  • [33] Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children
    Aya Inaba
    Yuko Hamasaki
    Kenji Ishikura
    Riku Hamada
    Tomoyuki Sakai
    Hiroshi Hataya
    Fumiyo Komaki
    Tetsuji Kaneko
    Masaaki Mori
    Masataka Honda
    Pediatric Nephrology, 2016, 31 : 425 - 434
  • [34] Treatment of steroid-resistant nephrotic syndrome in the genomic era
    Bensimhon, Adam R.
    Williams, Anna E.
    Gbadegesin, Rasheed A.
    PEDIATRIC NEPHROLOGY, 2019, 34 (11) : 2279 - 2293
  • [35] The importance of genetic study in steroid-resistant nephrotic syndrome
    Vahed, Sepideh Zununi
    Sani, Hakimeh Moghaddas
    Rajabzadeh, Sima
    Nariman-Saleh-Fam, Ziba
    Hejazian, Mina
    Vahed, Fatemeh Zununi
    Khatibi, Seyed Mandi Hosseiniyan
    Shoja, Mohammadali Mohajel
    Ardalan, Mohammadreza
    JOURNAL OF RENAL INJURY PREVENTION, 2019, 8 (04): : 271 - 282
  • [36] Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO
    Lombel, Rebecca M.
    Hodson, Elisabeth M.
    Gipson, Debbie S.
    PEDIATRIC NEPHROLOGY, 2013, 28 (03) : 409 - 414
  • [37] Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO
    Rebecca M. Lombel
    Elisabeth M. Hodson
    Debbie S. Gipson
    Pediatric Nephrology, 2013, 28 : 409 - 414
  • [38] Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
    Zhijuan Kang
    Zhihui Li
    Cuirong Duan
    Tianhui Wu
    Mai Xun
    Yunfeng Ding
    Yi Zhang
    Liang Zhang
    Yan Yin
    Pediatric Nephrology, 2015, 30 : 1121 - 1129
  • [39] Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome
    Vasudevan, Anil
    Thergaonkar, Ranjeet
    Mantan, Mukta
    Sharma, Jyoti
    Khandelwal, Priyanka
    Hari, Pankaj
    Sinha, Aditi
    Bagga, Arvind
    INDIAN PEDIATRICS, 2021, 58 (07) : 650 - 666
  • [40] Using Mycophenolate Mofetil in Steroid-Resistant Nephrotic Syndrome
    Ganji, Mohammad Reza
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2012, 6 (05) : 323 - 325